Composition
- Active ingredients
- CARMUSTINE 300MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CARMUSTINE 100MG/VIAL · InjectableANDA210179-001 · Prescription
- CARMUSTINE 100MG/VIAL · InjectableANDA213207-001 · Prescription
- CARMUSTINE 100MG/VIAL · InjectableANDA211229-001 · Prescription
- CARMUSTINE 100MG/VIAL · InjectableANDA213460-001 · Prescription
- CARMUSTINE 100MG/VIAL · InjectableANDA214117-001 · Discontinued
- CARMUSTINE 100MG/VIAL · InjectableANDA211011-001 · Discontinued
- CARMUSTINE 100MG/VIAL · InjectableANDA209278-001 · Prescription
- CARMUSTINE 100MG/VIAL · InjectableANDA211202-001 · Discontinued
- CARMUSTINE 100MG/VIAL · InjectableANDA214814-001 · Prescription
- CARMUSTINE 100MG/VIAL · InjectableANDA215368-001 · Discontinued
- CARMUSTINE 50MG/VIAL · PowderNDA215000-001 · Discontinued
- CARMUSTINE 300MG/VIAL · PowderThis page
- CARMUSTINE 100MG/VIAL · InjectableANDA215730-001 · Prescription
At a glance
- Brand name
- Carmustine
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Accord Hlthcare
- Status
- Discontinued
- FDA approval
- 16 May 2022
- Application
- NDA215000-002